l

The content of this website is intended for healthcare professionals only

Brexit: Drug export ban advised by pharmacy bosses

Scottish CMO issues advice on no-deal Brexit

Jo Carlowe

Friday, 29 March 2019

Pharmaceutical industry leaders are calling for a temporary ban on drugs exports to prevent shortages in the event of a no-deal Brexit.

Speaking to the BBC the Association of the British Pharmaceutical Industry (ABPI) called for a temporary export ban on certain medicines to stop the practice of ‘parallel trade’ in which wholesalers buy products intended by manufacturers for one market and export them to another EU member state.


The ABPI warned that a drop in the value of the pound would create an incentive for this.

A Department of Health and Social care spokesperson said: "We are aware of concerns raised about this issue and continue to work closely with the NHS, industry and the supply chain to ensure patients continue to access medicines in the same way they do now - whatever the EU exit outcome.”

Meanwhile, in Scotland, health professionals have been given further advice on preparations for a no-deal Brexit from the chief medical officer (CMO) and chief pharmaceutical officer.

A joint letter outlines preparations being made to enable the NHS to respond to and manage medicine shortages if the UK leaves the EU without a deal, as well as the support that will be given to prescribers and pharmacists.

The letter urges the public, GPs, community pharmacies and hospitals not to stockpile medicines.

This follows on from the chief pharmaceutical officer’s letter on possible medicine shortages which was sent to those working within the health sector in January.

 

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470